6-[(aminoalkyl)amino]-substituted 7H-benzo[e]perimidin-7-ones as novel antineoplastic agents. Synthesis and biological evaluation. 1993

B Stefańska, and M Dzieduszycka, and S Martelli, and J Tarasiuk, and M Bontemps-Gracz, and E Borowski
Department of Pharmaceutical Technology and Biochemistry, Technical University of Gdańsk, Poland.

A class of chromophore-modified anthracenediones with an additional pyrimidine ring incorporated into the chromophore system has been obtained in an attempt to provide compounds with diminished peroxidation activity and thus potentially lowered cardiotoxicity. Their synthesis was carried out by the reaction of 6-amino- or 6-hydroxy-7H-benzo[e]perimidin-7-one with a number of alkylamines. Potent activity was demonstrated in vitro against murine L1210 leukemia cells (equipotent with ametantrone) as well as against P388 leukemia in vivo (% T/C = 130-255). We observed that the benzoperimidines did not stimulate free radical formation, perhaps due to their poor substrate properties for NADH dehydrogenase.

UI MeSH Term Description Entries
D007939 Leukemia L1210 An experimental LYMPHOCYTIC LEUKEMIA of mice. Leukemia L 1210,L 1210, Leukemia,L1210, Leukemia
D007941 Leukemia P388 An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. P388D(1) Leukemia,P388, Leukemia
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000880 Anthraquinones Compounds based on ANTHRACENES which contain two KETONES in any position. Substitutions can be in any position except on the ketone groups. Anthracenedione,Anthracenediones,Anthranoid,Anthraquinone,Anthraquinone Compound,Anthraquinone Derivative,Dianthraquinones,Dianthrones,Anthranoids,Anthraquinone Compounds,Anthraquinone Derivatives,Compound, Anthraquinone,Derivative, Anthraquinone
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

B Stefańska, and M Dzieduszycka, and S Martelli, and J Tarasiuk, and M Bontemps-Gracz, and E Borowski
April 2002, Bioorganic & medicinal chemistry,
B Stefańska, and M Dzieduszycka, and S Martelli, and J Tarasiuk, and M Bontemps-Gracz, and E Borowski
March 1984, Journal of medicinal chemistry,
B Stefańska, and M Dzieduszycka, and S Martelli, and J Tarasiuk, and M Bontemps-Gracz, and E Borowski
October 1990, Journal of medicinal chemistry,
B Stefańska, and M Dzieduszycka, and S Martelli, and J Tarasiuk, and M Bontemps-Gracz, and E Borowski
January 1990, Journal of medicinal chemistry,
B Stefańska, and M Dzieduszycka, and S Martelli, and J Tarasiuk, and M Bontemps-Gracz, and E Borowski
May 2021, Journal of medicinal chemistry,
B Stefańska, and M Dzieduszycka, and S Martelli, and J Tarasiuk, and M Bontemps-Gracz, and E Borowski
September 1985, Journal of medicinal chemistry,
B Stefańska, and M Dzieduszycka, and S Martelli, and J Tarasiuk, and M Bontemps-Gracz, and E Borowski
January 2003, Arzneimittel-Forschung,
B Stefańska, and M Dzieduszycka, and S Martelli, and J Tarasiuk, and M Bontemps-Gracz, and E Borowski
January 2015, Current topics in medicinal chemistry,
B Stefańska, and M Dzieduszycka, and S Martelli, and J Tarasiuk, and M Bontemps-Gracz, and E Borowski
December 2011, European journal of medicinal chemistry,
B Stefańska, and M Dzieduszycka, and S Martelli, and J Tarasiuk, and M Bontemps-Gracz, and E Borowski
January 2005, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!